ºÚÁϳԹÏ×ÊÔ´

1. Probiotics as adjunct preventive therapy for childhood diarrhea and antimicrobial resistance in Africa (PRoRota)
2. Probiotic treatment of newborns to reduce colonization and disease caused by resistant bacteria (ProRIDE).

1. (Combatting Anti-Microbial Resistance with Interdisciplinary Approaches)
   • Surveillance and metagenomic tracking of antimicrobial resistance genes in environmental and clinical samples using machine learning approaches ().
   • Learning and predicting the pathways of antimicrobial resistance evolution using hypercubic transition path sampling, computational and mathematical approach to learn evolutionary pathways using large-scale biological data ()
   • Risk communication and perception of antimicrobial resistance in the public and among healthcare workers: Knowledge needed to develop new policies and interventions ().
2. Antimicrobial stewardship in hospitals, resistance selection and transfer in a One Health context ().
3. Consequences of antibiotic resistance after preventive treatment with cotrimoxazole in HIV patients (CoTrimResist).
4. Innate and adaptive immunity within the early versus late BCG vaccination in HIV-1 exposed infants (BCGI).
5. Bloodstream infections and antibiotic resistance among patients in Tanzania.
6. Development of methods for detection of the malaria parasite’s genetic material.

1. Immune reasponse against Giardia in humans ().
2. Detection and prevalence of intestinal parasites in Norway, including genotyping of circulating Giardia and Cryptosporidium variants (TaDiGe).
3. Improved diagnostics for Cryptosporidium in low-income countries (, CryptoT&T).
4. Exposure study to enterotoxigenic Escherichia coli bacteria and vaccine development (ETEC).
5. Causes of diarrhea among children under five years of age in Tanzania.

1. Prevention of long covid-19 in Norway by treatment with Paxlovid ().
2. The Coordination Mechanism for Cohorts and Trials ().

1. Investigation of the protocols for supportive treatment in Ebola treatment centers in Sierra Leone and other affected countries.
2. Evaluation of the efficacy of a post-exposure prophylaxis strategy in contacts at high risk of developing Ebola virus disease.

1. Bacterial strain colonization in fecal microbiota transfer therapy in patients with irritable bowel syndrome ().
2. The significance of blood volume in blood cultures in children: evaluation of weight- and age-adjusted volumes for growth of pathogenic microbes and microbial contamination.

1. Developing vaccines against diarrhea caused by enterotoxigenic Shigella (EntVac)
2. Developing vaccines against diarrhea caused by enterotoxigenic Escherichia coli (ETECVac)
3. Transplantation of intestinal microbiota in primary Clostridioides difficile infections ()
4. Gastrointestinal complaints and fatigue among patients and a control group after the giardiasis outbreak in Bergen in 2004 ().

This is a selection of the Group's key publications. For detailed lists please refer to individual project pages.
 

1. (2026)
2.  (2025)
3. (2025)
4. (2025)
5. (2024)
6.  (2024)
7. (2024)
8. (2023)
9. (2023)
10. (2022)
11. (2021)
12. (2020)

1. Annette Onken: . (2024)
2. Øystein Haarklau Johansen: (2023)
3. Joel Manyahi: (2022)
4. Christina Skår Saghaug: (2021)
5. Thandile Nkosi: (2021)
6. Sunniva Todnem Sakkestad: Enterotoxigenic Escherichia coli infection and diarrhoea - experimental infection studies and immunological characterisation to guide vaccine development. (2021)
7. Sabrina Moyo: (2014)
8. Gro Elizabeth Ann Strøm: (2014)
9. Kurt Hanevik: (2012)
10. Kristine Mørch: (2010)
11. Bjørn Blomberg: (2007)